Related Experiment Video

Updated: Jun 15, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

[Treatment of viral hepatitis in children]

Alemka Jaklin Kekez1

  • 1Department of Gastroenterology, Hepatology and Nutrition, Zagreb Children's Hospital, Zagreb, Croatia.

Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti
|March 5, 2010
PubMed

Insights

Pediatric chronic hepatitis B treatment remains monotherapy, while combined therapy is best for hepatitis C. Early screening for liver cancer is crucial for children with viral hepatitis.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Infectious Diseases

Background:

  • Current treatment guidelines for pediatric chronic hepatitis B and C show no significant national differences.
  • Monotherapy with interferon alfa or lamivudine is the standard for chronic hepatitis B in children.
  • Combined therapy for hepatitis B shows promise but is not yet standard practice.

Purpose of the Study:

  • To review and compare current recommendations for treating chronic viral hepatitis in children.
  • To highlight effective prevention strategies and screening protocols for pediatric hepatitis.
  • To emphasize the importance of early detection of hepatocellular carcinoma in children with chronic viral hepatitis.

Main Methods:

  • Comparative analysis of existing national treatment recommendations.
  • Review of recent pilot studies and multicenter trials on pediatric hepatitis therapies.
  • Assessment of current prevention strategies, including infant and school-aged child immunization programs.

Main Results:

  • Chronic hepatitis B treatment in children largely relies on monotherapy (interferon alfa or lamivudine).
  • Combined therapy with interferon alfa-2b and ribavirin is the preferred treatment for chronic hepatitis C in children.
  • Immunization programs for infants and sixth-graders are recommended to decrease hepatitis B prevalence.

Conclusions:

  • Pediatric chronic viral hepatitis management requires adherence to established guidelines while considering emerging therapies.
  • Enhanced immunization strategies are vital for reducing the incidence of chronic hepatitis B.
  • Regular screening for hepatocellular carcinoma using alpha fetoprotein levels and liver ultrasonography is essential for at-risk children.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...